ELECTRE is a single-center, randomized, prospective, longitudinal, controlled, two-arm, single-blind study lasting 4 weeks (P1 investigation phase) after a 4-week run-in period.
The study is followed by a 4-week extension phase (P2) in which all participants will be treated with active TENS.
Randomization will be balanced according to a 1:1 ratio.
Women aged ≥ 18 years
Endometriosis and/or adenomyosis diagnosed by imaging and/or histology
Undergoing continuous, stable, and functional hormone treatment (with no menstruation) for at least 2 months
No change in hormone treatment planned for the duration of the study
Pregnant or breastfeeding women
Menopausal women
Patients who, in the investigator's opinion, have experienced an acute worsening of endometriosis symptoms in the last 28 days
Patients with altered sensitivity in the area where the device is applied (hypoesthesia)